AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:AKBM - NO0010886625 - Common Stock
90.2 NOK
-1.1 (-1.2%)
Overall AKBM gets a fundamental rating of 4 out of 10. We evaluated AKBM against 61 industry peers in the Food Products industry. There are concerns on the financial health of AKBM while its profitability can be described as average. AKBM is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
AKBM had positive earnings in the past year.
AKBM had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AKBM reported negative net income in multiple years.
Of the past 5 years AKBM 4 years had a positive operating cash flow.
1.2 Ratios
AKBM has a Return On Assets of 44.73%. This is amongst the best in the industry. AKBM outperforms 100.00% of its industry peers.
AKBM has a better Return On Equity (115.79%) than 100.00% of its industry peers.
The Return On Invested Capital of AKBM (1.30%) is worse than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 44.73% | ||
| ROE | 115.79% | ||
| ROIC | 1.3% |
ROA(3y)16.04%
ROA(5y)9.26%
ROE(3y)36.62%
ROE(5y)21.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AKBM has a Profit Margin of 67.04%. This is amongst the best in the industry. AKBM outperforms 100.00% of its industry peers.
AKBM's Operating Margin of 2.05% is on the low side compared to the rest of the industry. AKBM is outperformed by 68.25% of its industry peers.
The Gross Margin of AKBM (43.26%) is better than 65.08% of its industry peers.
AKBM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.05% | ||
| PM (TTM) | 67.04% | ||
| GM | 43.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.36%
2. Health
2.1 Basic Checks
AKBM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AKBM has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, AKBM has about the same amount of shares outstanding.
AKBM has a better debt/assets ratio than last year.
2.2 Solvency
AKBM has an Altman-Z score of 1.53. This is a bad value and indicates that AKBM is not financially healthy and even has some risk of bankruptcy.
AKBM has a worse Altman-Z score (1.53) than 65.08% of its industry peers.
AKBM has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.06, AKBM is not doing good in the industry: 69.84% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.53 |
ROIC/WACC0.15
WACC8.51%
2.3 Liquidity
AKBM has a Current Ratio of 2.62. This indicates that AKBM is financially healthy and has no problem in meeting its short term obligations.
AKBM has a better Current ratio (2.62) than 87.30% of its industry peers.
AKBM has a Quick Ratio of 1.25. This is a normal value and indicates that AKBM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AKBM (1.25) is better than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.62 | ||
| Quick Ratio | 1.25 |
3. Growth
3.1 Past
AKBM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15747.24%, which is quite impressive.
The Revenue for AKBM has decreased by -15.34% in the past year. This is quite bad
AKBM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.17% yearly.
EPS 1Y (TTM)15747.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-8.77%
Revenue growth 5Y-4.17%
Sales Q2Q%-41.17%
3.2 Future
AKBM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 96.03% yearly.
AKBM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.59% yearly.
EPS Next Y70%
EPS Next 2Y117.56%
EPS Next 3Y96.03%
EPS Next 5YN/A
Revenue Next Year-14.74%
Revenue Next 2Y-1.39%
Revenue Next 3Y2.27%
Revenue Next 5Y20.59%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
AKBM is valuated cheaply with a Price/Earnings ratio of 4.46.
Based on the Price/Earnings ratio, AKBM is valued cheaply inside the industry as 96.83% of the companies are valued more expensively.
AKBM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.39.
Based on the Price/Forward Earnings ratio of 36.73, the valuation of AKBM can be described as expensive.
69.84% of the companies in the same industry are cheaper than AKBM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AKBM to the average of the S&P500 Index (23.84), we can say AKBM is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.46 | ||
| Fwd PE | 36.73 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKBM indicates a slightly more expensive valuation: AKBM is more expensive than 69.84% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 20.78 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AKBM's earnings are expected to grow with 96.03% in the coming years.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y117.56%
EPS Next 3Y96.03%
5. Dividend
5.1 Amount
No dividends for AKBM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
OSL:AKBM (12/19/2025, 7:00:00 PM)
90.2
-1.1 (-1.2%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners7%
Inst Owner ChangeN/A
Ins Owners3.22%
Ins Owner ChangeN/A
Market Cap7.91B
Revenue(TTM)258.20M
Net Income(TTM)173.10M
Analysts77.78
Price Target86.7 (-3.88%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend43.3
Dividend Growth(5Y)N/A
DP215.6%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)6.25%
EPS NY rev (3m)-15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.46 | ||
| Fwd PE | 36.73 | ||
| P/S | 3.01 | ||
| P/FCF | N/A | ||
| P/OCF | 189.65 | ||
| P/B | 5.2 | ||
| P/tB | 28.38 | ||
| EV/EBITDA | 20.78 |
EPS(TTM)20.22
EY22.42%
EPS(NY)2.46
Fwd EY2.72%
FCF(TTM)-1.76
FCFYN/A
OCF(TTM)0.48
OCFY0.53%
SpS29.95
BVpS17.34
TBVpS3.18
PEG (NY)0.06
PEG (5Y)N/A
Graham Number88.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 44.73% | ||
| ROE | 115.79% | ||
| ROCE | 1.69% | ||
| ROIC | 1.3% | ||
| ROICexc | 1.39% | ||
| ROICexgc | 2.38% | ||
| OM | 2.05% | ||
| PM (TTM) | 67.04% | ||
| GM | 43.26% | ||
| FCFM | N/A |
ROA(3y)16.04%
ROA(5y)9.26%
ROE(3y)36.62%
ROE(5y)21.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.36%
F-Score5
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.5 | ||
| Cap/Depr | 48.25% | ||
| Cap/Sales | 7.47% | ||
| Interest Coverage | 0.39 | ||
| Cash Conversion | 9.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.62 | ||
| Quick Ratio | 1.25 | ||
| Altman-Z | 1.53 |
F-Score5
WACC8.51%
ROIC/WACC0.15
Cap/Depr(3y)77.43%
Cap/Depr(5y)88.04%
Cap/Sales(3y)14.31%
Cap/Sales(5y)16.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15747.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y70%
EPS Next 2Y117.56%
EPS Next 3Y96.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-8.77%
Revenue growth 5Y-4.17%
Sales Q2Q%-41.17%
Revenue Next Year-14.74%
Revenue Next 2Y-1.39%
Revenue Next 3Y2.27%
Revenue Next 5Y20.59%
EBIT growth 1Y60.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year170.83%
EBIT Next 3Y67.11%
EBIT Next 5YN/A
FCF growth 1Y62.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.58%
OCF growth 3Y155.79%
OCF growth 5Y-0.17%
AKER BIOMARINE ASA / AKBM.OL FAQ
Can you provide the ChartMill fundamental rating for AKER BIOMARINE ASA?
ChartMill assigns a fundamental rating of 4 / 10 to AKBM.OL.
What is the valuation status for AKBM stock?
ChartMill assigns a valuation rating of 4 / 10 to AKER BIOMARINE ASA (AKBM.OL). This can be considered as Fairly Valued.
What is the profitability of AKBM stock?
AKER BIOMARINE ASA (AKBM.OL) has a profitability rating of 4 / 10.
What are the PE and PB ratios of AKER BIOMARINE ASA (AKBM.OL) stock?
The Price/Earnings (PE) ratio for AKER BIOMARINE ASA (AKBM.OL) is 4.46 and the Price/Book (PB) ratio is 5.2.
What is the financial health of AKER BIOMARINE ASA (AKBM.OL) stock?
The financial health rating of AKER BIOMARINE ASA (AKBM.OL) is 3 / 10.